Get started
Author

Sean Wei Xiang Ong

Observed names: Ong, Sean Wei Xiang, S Ong, S.W.X. Ong, Sean Wei Xiang Ong, Sean Ong, Sean W X Ong, Sean W. Ong, Sean W. X. Ong, Sean W.X. Ong, Sean WX Ong, Sean WX. Ong, Siew‐Wai Fong
Institutions: The Royal Melbourne Hospital, Sunnybrook Health Science Centre, The University of Melbourne, University of Toronto, Peter Doherty Institute, Institute for Clinical Evaluative Sciences, Sunnybrook Hospital
Observed institutions: Agency for Science, Technology and Research, Ministry of Health, The Royal Melbourne Hospital, Royal Children's Hospital, Sunnybrook Health Science Centre, SingHealth, The University of Melbourne, National University of Singapore, Nanyang Technological University, University of Toronto, Bellvitge University Hospital, Tan Tock Seng Hospital, Charles Darwin University, Menzies School of Health Research, Institut d'Investigació Biomédica de Bellvitge, Peter Doherty Institute, MOH Holdings, Institute for Clinical Evaluative Sciences, Murdoch Children's Research Institute, National Centre for Infectious Diseases, Sunnybrook Hospital, Sunnybrook Research Institute, Infectious Diseases Labs, National Healthcare Group
ORCID: 0000-0002-8570-436X
Observed ORCIDs: 0000-0002-8570-436X, 0000-0002-5326-489X
OpenAlex ID: A5015431342
Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient
2020 · Sean Wei Xiang Ong, Yian Kim Tan, et al. · JAMA · 2,140
PDF
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
2020 · Barnaby Edward Young, Sean Wei Xiang Ong, et al. · JAMA · 2,058
PDF
Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients
2020 · Po Ying Chia, Kristen Kelli Coleman, et al. · Nature Communications · 934
PDF
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)
2021 · Sean Wei Xiang Ong, Calvin J Chiew, et al. · Clinical Infectious Diseases · 383
PDF
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
2021 · Wan Ni Chia, Feng Zhu, et al. · The Lancet Microbe · 359
PDF
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
2021 · Po Ying Chia, Sean Wei Xiang Ong, et al. · Clinical Microbiology and Infection · 330
PDF
Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing
2021 · Kristen K Coleman, Douglas Jie Wen Tay, et al. · Clinical Infectious Diseases · 263
PDF
Epidemiological and Clinical Predictors of COVID-19
2020 · Yinxiaohe Sun, Vanessa Koh, et al. · Clinical Infectious Diseases · 204
PDF
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity
2020 · Barnaby E Young, Sean W X Ong, et al. · Clinical Infectious Diseases · 199
PDF
Clinical and Virological Features of SARS-CoV-2 Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta)
2021 · Sean Wei Xiang Ong, Calvin J. Chiew, et al. · SSRN Electronic Journal · 134
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
2021 · Sean Wei Xiang Ong, Siew-Wai Fong, et al. · Open Forum Infectious Diseases · 114
PDF
Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis
2021 · Danielle K. Longmore, Jessica E. Miller, et al. · Diabetes Care · 96
PDF
Absence of contamination of personal protective equipment (PPE) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2020 · Sean Wei Xiang Ong, Yian Kim Tan, et al. · Infection Control and Hospital Epidemiology · 68
PDF
Association of Higher Body Mass Index With Severe Coronavirus Disease 2019 (COVID-19) in Younger Patients
2020 · Sean Wei Xiang Ong, Barnaby Edward Young, et al. · Clinical Infectious Diseases · 56
PDF
Unlocking the DOOR—how to design, apply, analyse, and interpret desirability of outcome ranking endpoints in infectious diseases clinical trials
2023 · Sean W.X. Ong, Neta Petersiel, et al. · Clinical Microbiology and Infection · 50
PDF
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial
2022 · Xuan Ying Poh, Chee Wah Tan, et al. · Clinical Infectious Diseases · 41
PDF
Lack of viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among PCR-positive air samples from hospital rooms and community isolation facilities
2021 · Sean Wei Xiang Ong, Yian Kim Tan, et al. · Infection Control and Hospital Epidemiology · 40
PDF
Predictors for development of critical illness amongst older adults with COVID-19: Beyond age to age-associated factors
2020 · Jun Pei Lim, Kristabella Yu Han Low, et al. · Archives of Gerontology and Geriatrics · 39
Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes
2021 · Sean Wei Xiang Ong, Barnaby Edward Young, et al. · The Lancet Infectious Diseases · 38
PDF
Severe dengue and liver involvement: an overview and review of the literature
2020 · Po Ying Chia, Tun-Linn Thein, et al. · Expert Review of Anti-infective Therapy · 35
Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection
2020 · Pei Hua Lee, Woo Chiao Tay, et al. · Clinical & Translational Immunology · 34
PDF
Environmental contamination in a coronavirus disease 2019 (COVID-19) intensive care unit—What is the risk?
2020 · Sean Wei Xiang Ong, Pei Hua Lee, et al. · Infection Control and Hospital Epidemiology · 33
PDF
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019
2020 · Sean Wei Xiang Ong, Wilnard Yeong Tze Tan, et al. · Clinical & Translational Immunology · 30
PDF
Blood Pressure Targets for Adults with Vasodilatory Shock — An Individual Patient Data Meta-Analysis
2024 · Federico Angriman, Neda Momenzade, et al. · NEJM Evidence · 29
Works count: 116
Citation count: 8,317
H-index: 26
I10-index: 49
Year
Topic
Type